Understanding and predicting ciprofloxacin minimum inhibitory concentration in Escherichia coli with machine learning by Pataki, BÁ, Matamoros, S, van der Putten, BCL, Remondini, D, Giampieri, E, Aytan-Aktug, D, Hendriksen, RS, Lund, O, Csabai, I, Schultsz, C, SPS COMPARE ML-AMR group, Ngo, H

Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx Renal by Mitchell, TJ, Turajlic, S, Rowan, A, Nicol, D, Farmery, JHR, O'Brien, T, Martincorena, I, Tarpey, P, Angelopoulos, N, Yates, LR, Butler, AP, Raine, K, Stewart, GD, Challacombe, B, Fernando, A, Lopez, JI, Hazell, S, Chandra, A, Chowdhury, S, Rudman, S, Soultati, A, Stamp, G, Fotiadis, N, Pickering, L, Au, L, Spain, L, Lynch, J, Stares, M, Teague, J, Maura, F, Wedge, DC, Horswell, S, Chambers, T, Litchfield, K, Xu, H, Stewart, A, Elaidi, R, Oudard, S, McGranahan, N, Csabai, I, Gore, M, Futreal, PA, Larkin, J, Lynch, AG, Szallasi, Z, Swanton, C, Campbell, PJ